Free Trial
NASDAQ:VCNX

Vaccinex (VCNX) Stock Price, News & Analysis

Vaccinex logo
$0.70 +0.02 (+2.94%)
As of 09:32 AM Eastern

About Vaccinex Stock (NASDAQ:VCNX)

Advanced

Key Stats

Today's Range
$0.70
$0.70
50-Day Range
$0.42
$1.05
52-Week Range
$0.25
$1.40
Volume
368 shs
Average Volume
2,832 shs
Market Capitalization
$1.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vaccinex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
8th Percentile Overall Score

VCNX MarketRank™: 

Vaccinex scored higher than 8% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Vaccinex.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vaccinex is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vaccinex is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Vaccinex's valuation and earnings.
  • Percentage of Shares Shorted

    0.22% of the float of Vaccinex has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaccinex has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Vaccinex has recently decreased by 3.45%, indicating that investor sentiment is improving.
  • Dividend Yield

    Vaccinex does not currently pay a dividend.

  • Dividend Growth

    Vaccinex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.22% of the float of Vaccinex has been sold short.
  • Short Interest Ratio / Days to Cover

    Vaccinex has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Vaccinex has recently decreased by 3.45%, indicating that investor sentiment is improving.
  • MarketBeat Follows

    1 people have added Vaccinex to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vaccinex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    51.50% of the stock of Vaccinex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    50.11% of the stock of Vaccinex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vaccinex's insider trading history.
Receive VCNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VCNX Stock News Headlines

Vaccinex, Inc. (NASDAQ:VCNX) Short Interest Update
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
See More Headlines

VCNX Stock Analysis - Frequently Asked Questions

Vaccinex's stock was trading at $0.98 at the start of the year. Since then, VCNX stock has decreased by 28.6% and is now trading at $0.70.

Vaccinex, Inc. (NASDAQ:VCNX) announced its earnings results on Monday, November, 8th. The company reported ($35.70) earnings per share (EPS) for the quarter, beating the consensus estimate of ($60.90) by $25.20. The firm earned $0.05 million during the quarter.

Shares of Vaccinex reverse split on Tuesday, February 20th 2024.The 1-14 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Vaccinex (VCNX) raised $45 million in an IPO on Thursday, August 9th 2018. The company issued 3,300,000 shares at a price of $12.00-$15.00 per share. Oppenheimer and BTIG served as the underwriters for the IPO and Ladenburg Thalmann was co-manager.

Shares of VCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaccinex investors own include Pfizer (PFE), VBI Vaccines (VBIV), OPKO Health (OPK), Plug Power (PLUG), Vaxart (VXRT), NIO (NIO) and SNDL (SNDL).

Company Calendar

Last Earnings
11/08/2021
Today
9/19/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VCNX
CIK
1205922
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($48.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.25 million
Net Margins
N/A
Pretax Margin
-4,787.89%
Return on Equity
N/A
Return on Assets
-383.58%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.77
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$388 thousand
Price / Sales
4.69
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.59) per share
Price / Book
-0.27

Miscellaneous

Outstanding Shares
2,600,000
Free Float
1,261,000
Market Cap
$1.82 million
Optionable
No Data
Beta
1.10

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:VCNX) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners